MAPT and dementia: Our initial study demonstrates tau pathology and neurodegeneration in hippocampus, gliosis and microglia activation in the whiter matter, making this model a valuable in vivo platform to investigate various vascular risk factors and structural and functional changes that may lead to dementia.